Follow
Curasight A/S
Spotlight (Sweden)
Curasight is a clinical development company based in Copenhagen, Denmark. The Company is a pioneer in the field of exploiting a novel Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (“uPAR”). The technology provides improved diagnosis and risk stratification in multiple cancer types, most notably for risk stratification in prostate cancer.
Sector:
HEALTH CARE
>
Biotechnology
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
CURAS
DK0061295797
Spotlight
Sweden (SE)
Details of share in Curasight A/S with ticker CURAS
Status
Inactive
Order book id
Amount of instruments
Par value
Market cap
Currency
DKK
First trading date
Sep 2020
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
14.40 DKK
200M DKK
03 Sep - 17 Sep 2020
IPO in Curasight A/S
Type
Ticker
ISIN
Market
OPTION
CURAS TO 1
DK0061408747
Spotlight
Sweden (SE)
Details of option in Curasight A/S with ticker CURAS TO 1
Status
Inactive
Order book id
Amount of instruments
1 986 250
Market cap
Currency
DKK
First trading date
08 Oct 2020
Terms
One (1) warrant gives the right to subscribe for one (1) new share at DKK 17.20 in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
17.20 DKK
16 Sep - 07 Oct 2021
Option exercise terms for CURAS TO 1
People
Ulrich Krasilnikoff
CEO
Per Falholt
Chairman of the board
Lars Trolle
Board member
Charlotte Vedel
Board member
Andreas Kjær
Board member
Ulrich Krasilnikoff
Board member
Company Details
Sector
HEALTH CARE

Address
Ole Maaløes Vej 3
Zip code
2200
City/district
København N
Country
Denmark (DK)
Registration number
35249389
LEI code
984500C9E3ADR98F1070
First trade date
08 Oct 2020
Registration date
22 May 2013
Short name
Curasight

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date